Abstract:Ethnopharmacological relevance: Dragon's blood has been used as a famous traditional medicine since ancient times by many cultures. It is a deep red resin, obtained from more than 20 different species of four distinct genera. Red resin of Dracaena cochinchinensis S.C. Chen, known as Chinese Dragon's Blood or Yunnan Dragon's Blood, has been shown to promote blood circulation, alleviate inflammation, and to treat stomach ulcers, diarrhea, diabetes, and bleeding. This study investigated an effective approach to identify natural therapeutic agents for neurodegeneration from herbal medicine. The dichloride extract and isolated effective constituents of Chinese Dragon's Blood showed quinone oxidoreductase 1 (NQO1) inducing activity and anti-inflammatory effect significantly, which are therapy targets of various neurodegenerative diseases.Materials and methods: Multiple chromatography and spectra analysis were utilized to afford effective constituents. Then Hepa 1c1c7 and BV-2 cells were employed to assay their NQO1 inducing and anti-inflammatory activities, respectively.Results: Bioactivities guided isolation afforded 21 effective constituents, including two new polymers cochinchinenene E (I), cochinchinenene F (2) and a new steroid dracaenol C (16). The main constituent 3 (weight percent 0.2%), 5 (weight percent 0.017%), 4 (weight percent 0.009%), 9 (weight percent 0.094%), 10 (weight percent 0.017%) and 8 (weight percent 0.006%) are responsible for the anti-inflammatory activities of Chinese Dragon's Blood. While, new compounds 1, 2 and known compounds 5, 11 showed good NQO1 inducing activities. The brief feature of the activities and structures was discussed accordingly.Conclusion: Overviewing the bioactivities and phytochemical study result, 4'-hydroxy-2,4-dimethoxydihydrochalcone (3) and pterostilbene (5) as effective constituents of Chinese Dragon's Blood, were found to be potential candidate therapeutic agents for neurodegenerative diseases. (C) 2014 Elsevier Ireland Ltd. All rights reserved.

Chemical Constituents from Dragon' S Blood of Dracaena Cambodiana

[Antibacterial Components from Artificially Induced Dragon's Blood of Dracaena Cambodiana].

Natural Potential Therapeutic Agents of Neurodegenerative Diseases from the Traditional Herbal Medicine Chinese Dragon׳s Blood

Dihydrochalcones and Homoisoflavanes from the Red Resin of Dracaena Cochinchinensis (chinese Dragon's Blood).

Chemical constituents from resin of Dracaena cochinchinensis

Metabolomics and quantitative analysis to determine differences in the geographical origins and species of Chinese dragon's blood

Flavonoid oligomers from Chinese dragon’s blood, the red resins of Dracaena cochinchinensis

A systematic review of the botanical, phytochemical and pharmacological profile of Dracaena cochinchinensis, a plant source of the ethnomedicine "dragon's blood"

A Systematic Review of the Botanical, Phytochemical and Pharmacological Profile of Dracaena cochinchinensis, a Plant Source of the Ethnomedicine “Dragon’s Blood”

[Microscopical Study of Original Plant of Chinese Drug "dragon's Blood" Dracaena Cochinchinensis and Distribution and Constituents Detection of Its Resin].

Antifungal and wound healing promotive compounds from the resins of Dracaena cochinchinensis

[LC-MS Guided Isolation of Two Anti-Inflammatory Cyclic Dihydrochalcane Trimers from Chinese Dragon's Blood].

Comprehensive metabolome characterization and comparison between two sources of Dragon’s blood by integrating liquid chromatography/mass spectrometry and chemometrics

Dragon's Blood from Dracaena Worldwide: Species, Traditional Uses, Phytochemistry and Pharmacology

Rapid identification of dragon blood samples from Daemonorops draco, Dracaena cinnabari and Dracaena cochinchinensis by MALDI-TOF mass spectrometry

Identification and Characterization of Chalcone Isomerase Genes Involved in Flavonoid Production in Dracaena cambodiana

Chemical constituents from Daphne pedunculata

Simultaneous Quantification of Five Major Constituents in Stems of Dracaena Plants and Related Medicinal Preparations from China and Vietnam by Hplc-Dad

Flavonoid Dimers from the Total Phenolic Extract of Chinese Dragon's Blood, the Red Resin of Dracaena Cochinchinensis.

Pharmacological Effects of Dragon’s Blood from Dranaena Cochinchinensis (lour.) S.C. Chen and Its Application in Cardiovascular Diseases

Homoisoflavonoid Derivatives from the Red Resin of Dracaena Cochinchinensis.